DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE
Active substance: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE
TABLET · DEXTROAMPHETAMINE SACCHARATE 3.75 mg/1, AMPHETAMINE ASPARTATE MONOHYDRATE 3.75 mg/1, DEXTROAMPHETAMINE SULFATE 3.75 mg/1, AMPHETAMINE SULFATE 3.75 mg/1
United StatesActive
Marketing holder: SUNRISE PHARMACEUTICAL, INC.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- DEXTROAMPHETAMINE SACCHARATE · 3.75 mg/1
- AMPHETAMINE ASPARTATE MONOHYDRATE · 3.75 mg/1
- DEXTROAMPHETAMINE SULFATE · 3.75 mg/1
- AMPHETAMINE SULFATE · 3.75 mg/1
Registration
- Registration number
- 11534-194
- Registration status
- Active
- Dispensing
- Prescription only
- Control marker
- CII
- Route
- ORAL
Sources
- product · openFDA NDC · 11534-194 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 11534-194 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 11534-194 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 11534-194 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 11534-194 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 11534-194 · Verified 2026-10-09 · open in source